MDT vs. PEN: Medtronic vs. Penumbra Stock Comparison

Company Profile

Medtronic (MDT) and Penumbra (PEN) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medtronic (MDT) is heavily traded at around 16.48M shares per day, whereas Penumbra (PEN) sees a more moderate 348.64K — larger orders in the latter may require more patience and tighter control over order sizing.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Medtronic (MDT) at 10.65% and Penumbra (PEN) at 10.67% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

For every dollar of sales, both Medtronic (MDT) at 13.93% and Penumbra (PEN) at 10.06% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Medtronic (MDT) at 19.33% operates in the top operating margin quartile, ahead of Penumbra (PEN) at 12.37%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both Medtronic (MDT) at 8.43% and Penumbra (PEN) at 17.50% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Penumbra (PEN) at 1,155.56% clears its industry range for EPS growth, a much stronger earnings trajectory than Medtronic (MDT) at 3.32%, which is closer to a typical peer reading.

Growth Metrics

Financial Strength

Medtronic (MDT) at 2.07 keeps current ratio within its industry’s typical mid-range, while Penumbra (PEN) at 5.89 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Penumbra (PEN) at 0.13 keeps leverage in the lower industry quartile, while Medtronic (MDT) at 0.55 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Penumbra (PEN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Medtronic (MDT) reports a yield of 2.72%, ranking against industry peers normally.

Penumbra (PEN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Medtronic (MDT) reports a payout of 70.02%, ranking against industry peers normally.

Dividend Metrics

Valuation

Medtronic (MDT) at 25.01 is near its industry’s usual P/E ratio, while Penumbra (PEN) at 80.41 sits in the richer quartile — PEN needs stronger growth or earnings quality to justify the premium.

Medtronic (MDT) at 3.47 is priced about in line with its industry on P/S ratio, while Penumbra (PEN) at 8.06 sits in the pricier quartile — PEN costs more per dollar of sales.

Medtronic (MDT) at 2.59 is valued about in line with its industry on P/B ratio, while Penumbra (PEN) at 7.95 carries an above-peer premium to book — PEN is pricier on assets.

Valuation Metrics